FAQ

Answers to the most common questions about HypoSpray transdermal delivery, prescription process, lab testing, and the BridgeMeds telehealth experience.

What is HypoSpray technology?

HypoSpray is BridgeMeds' transdermal spray format applied to the skin — a needle-free way to deliver compounded preparations. Compounded medications are not FDA-approved and are not equivalent to brand-name drugs.

Do I need a prescription?

Yes. You complete a brief online health assessment, and a U.S.-licensed provider reviews your information and, when clinically appropriate, may prescribe a treatment that is then dispensed by a licensed pharmacy. BridgeMeds itself does not prescribe or dispense.

How long does it take to get started?

The online assessment takes about five minutes. A licensed provider reviews your submission, typically within one to two business days. If a treatment is prescribed, it ships to your door.

Is BridgeMeds available in all 50 states?

BridgeMeds facilitates telehealth access with U.S.-licensed providers and licensed pharmacy partners across the United States. Provider availability and treatment eligibility depend on your state and your clinical assessment.

What treatments can BridgeMeds help with?

BridgeMeds supports categories including testosterone replacement therapy (TRT), GLP-1 weight management, women's hormone replacement therapy, sexual health, peptide therapy, thyroid support, and at-home lab testing. Some options are compounded medications, which are not FDA-approved and not equivalent to brand-name drugs. Whether any treatment is appropriate is a clinical decision made by a licensed provider.